Tocotrienol Supplementa as A Senolytic Agent in Middle-aged Adults | MicrobiomeTrials← Back to trialsNCT07637487
Tocotrienol Supplementa as A Senolytic Agent in Middle-aged Adults
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-10-31Est. Completion: 2024-12-19
Enrollment target: 220 participants Locations- National University of Malaysia, Kuala Lumpur, Kuala Lumpur, Malaysia
Other microbiome trials you might be interested in
Frailty
This pilot study tested whether a new program for older adults with frailty could realistically be carried out in primar…
San Sebastián, SpainCompleted Sep 25, 2025
Breast CancerAnthracycline Related Cardiotoxicity in Breast CancerVirtual RealityTrastuzumab
The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experienc…
Richmond, United StatesEst. completion Jul 30, 2026
Phase 1
Recruiting
This study is testing a new treatment for Frontotemporal Dementia (FTD) - a progressive brain disease that affects perso…
Multiple LocationsEst. completion Oct 31, 2027